Assessment of ALK Rearrangement in Non-small Cell Lung Cancer: Using Enhancing Immunohistochemical Way and Fluorescence in situ Hybridization

Background and objective Besides epidermal growth factor receptor (EGFR) mutation, the non-small cell lung cancer (NSCLC) of anaplastic lymphoma kinase (ALK) rearrangement becomes another important clinical subtype. A specific and high-sensitive and economical detection way is convenience for identi...

Full description

Bibliographic Details
Main Authors: Hui MENG, Xianzheng GAO, Lan ZHANG, Fang LIU, Wencai LI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.04
_version_ 1818684770810331136
author Hui MENG
Xianzheng GAO
Lan ZHANG
Fang LIU
Wencai LI
author_facet Hui MENG
Xianzheng GAO
Lan ZHANG
Fang LIU
Wencai LI
author_sort Hui MENG
collection DOAJ
description Background and objective Besides epidermal growth factor receptor (EGFR) mutation, the non-small cell lung cancer (NSCLC) of anaplastic lymphoma kinase (ALK) rearrangement becomes another important clinical subtype. A specific and high-sensitive and economical detection way is convenience for identification of ALK positive NSCLC quickly and accurately. So the objective of our research is to detect ALK rearrangement in 172 cases of NSCLC by using enhancing immunohistochemical way (ventana-IHC, V-IHC). Methods ALK rearrangement in 172 NSCLC samples was detected by using V-IHC, and positive staining cases were further verified by fluorescence in situ hybridization (FISH). Results Among 172 NSCLC cases, there were 12 positive staining. The positive results were confirmed by FISH and 11 cases were FISH positive. The overall concordance between V-IHC and FISH is 91.7% (11/12). Conclusion The V-IHC method is a reliable method for ALK arrangement and could be used in clinical screen and diagnosis.
first_indexed 2024-12-17T10:55:55Z
format Article
id doaj.art-d2b042dc7bd7450985d091bc76e450d8
institution Directory Open Access Journal
issn 1009-3419
language zho
last_indexed 2024-12-17T10:55:55Z
publishDate 2015-02-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj.art-d2b042dc7bd7450985d091bc76e450d82022-12-21T21:51:49ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34192015-02-01182757910.3779/j.issn.1009-3419.2015.02.04Assessment of ALK Rearrangement in Non-small Cell Lung Cancer: Using Enhancing Immunohistochemical Way and Fluorescence in situ HybridizationHui MENG0Xianzheng GAO1Lan ZHANG2Fang LIU3Wencai LI4Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaPfizer Oncology Medical Affairs, Chengdu 610041, ChinaDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaBackground and objective Besides epidermal growth factor receptor (EGFR) mutation, the non-small cell lung cancer (NSCLC) of anaplastic lymphoma kinase (ALK) rearrangement becomes another important clinical subtype. A specific and high-sensitive and economical detection way is convenience for identification of ALK positive NSCLC quickly and accurately. So the objective of our research is to detect ALK rearrangement in 172 cases of NSCLC by using enhancing immunohistochemical way (ventana-IHC, V-IHC). Methods ALK rearrangement in 172 NSCLC samples was detected by using V-IHC, and positive staining cases were further verified by fluorescence in situ hybridization (FISH). Results Among 172 NSCLC cases, there were 12 positive staining. The positive results were confirmed by FISH and 11 cases were FISH positive. The overall concordance between V-IHC and FISH is 91.7% (11/12). Conclusion The V-IHC method is a reliable method for ALK arrangement and could be used in clinical screen and diagnosis.http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.04Lung neoplasmsALKVentana-IHCFISH
spellingShingle Hui MENG
Xianzheng GAO
Lan ZHANG
Fang LIU
Wencai LI
Assessment of ALK Rearrangement in Non-small Cell Lung Cancer: Using Enhancing Immunohistochemical Way and Fluorescence in situ Hybridization
Chinese Journal of Lung Cancer
Lung neoplasms
ALK
Ventana-IHC
FISH
title Assessment of ALK Rearrangement in Non-small Cell Lung Cancer: Using Enhancing Immunohistochemical Way and Fluorescence in situ Hybridization
title_full Assessment of ALK Rearrangement in Non-small Cell Lung Cancer: Using Enhancing Immunohistochemical Way and Fluorescence in situ Hybridization
title_fullStr Assessment of ALK Rearrangement in Non-small Cell Lung Cancer: Using Enhancing Immunohistochemical Way and Fluorescence in situ Hybridization
title_full_unstemmed Assessment of ALK Rearrangement in Non-small Cell Lung Cancer: Using Enhancing Immunohistochemical Way and Fluorescence in situ Hybridization
title_short Assessment of ALK Rearrangement in Non-small Cell Lung Cancer: Using Enhancing Immunohistochemical Way and Fluorescence in situ Hybridization
title_sort assessment of alk rearrangement in non small cell lung cancer using enhancing immunohistochemical way and fluorescence in situ hybridization
topic Lung neoplasms
ALK
Ventana-IHC
FISH
url http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.04
work_keys_str_mv AT huimeng assessmentofalkrearrangementinnonsmallcelllungcancerusingenhancingimmunohistochemicalwayandfluorescenceinsituhybridization
AT xianzhenggao assessmentofalkrearrangementinnonsmallcelllungcancerusingenhancingimmunohistochemicalwayandfluorescenceinsituhybridization
AT lanzhang assessmentofalkrearrangementinnonsmallcelllungcancerusingenhancingimmunohistochemicalwayandfluorescenceinsituhybridization
AT fangliu assessmentofalkrearrangementinnonsmallcelllungcancerusingenhancingimmunohistochemicalwayandfluorescenceinsituhybridization
AT wencaili assessmentofalkrearrangementinnonsmallcelllungcancerusingenhancingimmunohistochemicalwayandfluorescenceinsituhybridization